Abstract
In this commentary, we distill key messages from a new framework for self-managed medication abortion developed by Global Doctors for Choice. Since Global Doctors for Choice supports doctors working in different contexts around the world, the document also highlights clinical concerns and advocacy opportunities for clinicians in both low- and high-resource settings, and in places with varying legal and administrative restrictions on abortion.
Original language | English |
---|---|
Pages (from-to) | 1-3 |
Number of pages | 3 |
Journal | Contraception |
Volume | 108 |
DOIs |
|
State | Published - Apr 2022 |
Externally published | Yes |
Keywords
- Medication abortion
- Mifepristone
- Misoprostol
- Self-managed abortion